drugset / Trial / NCT02543931
Curcuma Longa L in Rheumatoid Arthritis
Phase 1
Terminated
3 enrolled
University of Arizona
National Center for Complementary and Integrative Health (NCCIH) · collabNational Institutes of Health (NIH) · collabVanderbilt University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to find out whether turmeric dietary supplements that are available over the counter for general use in the United States are safe and useful when taken specifically for the treatment of rheumatoid arthritis (RA) and how the active principles in turmeric are broken down and metabolized by the body in individuals with RA.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-06
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcuminoids | Traditional medicine (herbal / TCM) | 250 mg | — |
| Subject | Curcuminoids | Traditional medicine (herbal / TCM) | 500 mg | — |